Latest News

19-01-2015 Phylogica Presentation at 2015 Biotech Showcase San Francisco
24-12-2014 Appendix 3B - New Issue Announcement
24-12-2014 Change of Director's Interest Notice
23-12-2014 Phylogica and Genentech Research & Licensing Agreement
27-11-2014 2014 AGM Presentation
News archive

Subscribe to our newsletter

Receive our latest news and announcements instantly


Phylogica is a leading peptide drug discovery company that utilises proprietary Phylomer peptide libraries and screening methodologies to identify unique peptide drug candidates for its pharmaceutical and biotechnology partners.

Phylomer® libraries contain the world's largest and most structurally diverse array of natural peptides. These peptides, known as Phylome® peptides, are sourced from evolutionary diverse microbes and they represent a new class of biological therapeutics. Phylomer® peptides display exceptional structural stability, specificity and affinity thereby giving them the potential to address disease targets that are intractable to small molecules and other protein biologics including antibodies. Read more



© 2015 Phylogica    |    ABN 48 098 391 961    |    Privacy Statement
Last updated: 21-01-2015    |    Website by Harmonic New Media and College Hill Life Sciences